Addiction Medicine
Conference Coverage
Higher buprenorphine doses help OUD patients stay in treatment
Opioid users stick around when they get more withdrawal relief, addiction clinic finds.
Conference Coverage
Buprenorphine update: Looser rules and a helpful injectable
As overdose epidemic continues, new regulations change landscape for opioid addiction therapy.
Latest News
Exercise and empathy can help back pain patients in primary care
Recent research suggests limited pain relief from analgesics and antidepressants, but patients report that doctors’ behavior makes a difference in...
News
FDA approves buprenorphine injection for opioid use disorder
Brixadi is approved in both weekly and monthly subcutaneous injectable formulations at varying doses.
News
Overdose deaths mark another record year, but experts hopeful
“But these numbers are still extraordinarily high. We shouldn’t suggest the crisis is in any way over.”
News
FDA moves to curb misuse of ADHD meds
The boxed warning will also advise heath care professionals to monitor patients closely for signs and symptoms of misuse, abuse, and addiction.
Article
Medication-assisted recovery for opioid use disorder: A guide
Considering offering medical intervention for OUD to reduce mortality? It’s essential to understand the clinical benefits, limitations, and...
News
Young men at highest schizophrenia risk from cannabis abuse
For young men aged 21-30, the proportion of preventable schizophrenia cases related to cannabis abuse disorder may be as high as 30%.
Conference Coverage
Survey reveals room for improvement in teen substance use screening
Lack of treatment and referral options impedes routine substance use screening in primary care settings.
News
Why is buprenorphine use flatlining?
“Clinicians are not maximizing opportunities to initiate buprenorphine treatment among patients with opioid addiction,” Dr. Kao-Ping Chua said.